Knoll Capital Management, LLC
MIAMI, FL · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$208.3M2026 Q3
Positions37
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.62.1%
What Changed This Quarter?
Top Holdings
BHVNEUR
Biohaven Pharmactl
16.2%
ENTX
Entera Bio
8.1%
MGTX
MeiraGTx
6.6%
RGLD
Royal Gold
6.0%
AEM
Agnico Eagle Mines
4.6%
Seabridge Gold
Seabridge Gold
4.3%
NUVB
Nuvation Bio
4.3%
OCUL
Ocular Therapeutix
4.2%
New / Increased
2 new · 3 increased
KZIANEW
Kazia Therapetics
0.6%
MREONEW
Mereo Biopharma
0.3%
WPM
Wheaton Precious Metals
2.5%
+212.6%
BHVNEUR
Biohaven Pharmactl
16.2%
+6.4%
VMET
Versamet Royalties
0.5%
+82.8%
Reduced / Exited
2 reduced · 2 sold out
PHYS
Sprott physical gold
2.9%
-50.4%
ENTX
Entera Bio
8.1%
-0.8%
ABEOEXIT
Abeona Therapeutics
1.4%
ALTEXIT
Altimmune
0.2%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.